287410 — Jeisys Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual income statement for Jeisys Medical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	81,296	116,550	143,030
Cost of Revenue
Gross Profit	—	—	56,647	79,575	98,970
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	53.5	102	57,692	82,514	106,716
Operating Profit	-53.5	-102	23,604	34,035	36,314
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	46.7	-28.4	13,093	33,886	35,498
Provision for Income Taxes
Net Income After Taxes	39.6	-21.2	13,761	27,012	25,108
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	39.6	-21.2	13,592	27,130	24,800
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	39.6	-21.2	13,592	28,393	24,941
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	9.35	-5.01	180	371	322
Dividends per Share